Nutriband - Rasio total nilai perusahaan marang pendapatan NTRB

Nutriband Inc. leverages the unique developments of Aversa transdermal systems, establishing a robust scientific and technological foundation. The EV-to-revenue trend confirms market expectations, with the metric fixed at 35543.21. While streamlined pharmacy distribution chains support business efficiency, high uncertainty persists due to stringent FDA oversight and a current lack of sales.
Nutriband Inc - rincian analitis lan metrik utama (NTRB)

The Enterprise Value-to-Revenue multiple reflects the market capitalization of Nutriband Inc. (NTRB) adjusted for net debt, comparing the total value of the business to its sales volume. This indicator assesses the investment attractiveness of the company's transdermal technologies, demonstrating how much investors are willing to pay per unit of revenue from patch commercialization while excluding the impact of debt load on the final valuation.